Latest SEC Form 4 insider trades with explainable signal scoring.
| Transaction | Flags | ||||||||
|---|---|---|---|---|---|---|---|---|---|
3d ago Jun 09, 2026 | Stevanato Group S.p.A. | Stocchi Mauro See Remarks | Buy · A | 2,101 | $0.00 | $0 | Neutral+1 | Late | |
3d ago Jun 26, 2026 | Lafayette Square USA, Inc. | Employees' Retirement System of the State of Hawaii 10% Owner | Buy · P | 1,365,188 | $14.65 | $20.00M | Bullish+51 | ||
3d ago Jun 24, 2026 | Context Therapeutics Inc. | Kantoff Philip W. Director | Buy · A | 45,000 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 25, 2026 | SOPHiA GENETICS SA | Verma Abhimanyu Chief Technology Officer | Sell · S | 6,944 | $5.51 | $38.2K | Neutral-7 | ||
3d ago Jun 25, 2026 | SOPHiA GENETICS SA | Menu Philippe Chief Medical Officer | Sell · S | 5,000 | $5.50 | $27.5K | Neutral-7 | ||
3d ago Jun 25, 2026 | Arqit Quantum Inc. | Lefebvre d'Ovidio Manfredi Director | Sell · S | 455 | $1.20 | $546 | Mild sell-16 | Deriv | |
3d ago Jun 24, 2026 | Arqit Quantum Inc. | Lefebvre d'Ovidio Manfredi Director | Sell · S | 659 | $1.20 | $791 | Mild sell-16 | Deriv | |
3d ago Jun 25, 2026 | Cerebras Systems Inc. | Susan Lior Director | Buy · J | 40,975 | — | — | Neutral+2 | ||
3d ago Jun 25, 2026 | Cerebras Systems Inc. | Susan Lior Director | Buy · J | 92,973 | — | — | Neutral+2 | ||
3d ago Jun 25, 2026 | Cerebras Systems Inc. | Susan Lior Director | Sell · J | 2,019,927 | — | — | Neutral+2 | ||
3d ago Jun 25, 2026 | Energy Vault Holdings, Inc. | Piconi Robert Chief Executive Officer · Director · 10% Owner | Buy · A | 3,886,000 | $0.00 | $0 | Neutral+8 | Deriv | |
3d ago Jun 24, 2026 | Enovix Corp | Chakravarthy Arthi Chief Legal Officer | Sell · F | 2,221 | $5.94 | $13.2K | Neutral+5 | ||
3d ago Jun 25, 2026 | Vinci Compass Investments Ltd. | Ribeiro Sergio Passos Chief Financial Officer | Sell · S | 5,626 | $9.59 | $54.0K | Neutral+7 | 10b5-1 | |
3d ago Jun 24, 2026 | Vinci Compass Investments Ltd. | Ribeiro Sergio Passos Chief Financial Officer | Sell · S | 3,897 | $9.58 | $37.3K | Neutral+7 | 10b5-1 | |
3d ago Jun 25, 2026 | SAB Biotherapeutics, Inc. | Kropotova Alexandra CHIEF MEDICAL OFFICER | Sell · F | 988 | — | — | Neutral+5 | ||
3d ago Jun 25, 2026 | StandardAero, Inc. | Newman Andrea Fischer Director | Buy · A | 6,608 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 15, 2026 | Semnur Pharmaceuticals, Inc. | Scilex Holding Co 10% Owner | Sell · J | 7,034,737 | $0.00 | $0 | Neutral0 | Late | |
3d ago Jun 25, 2026 | Macy's, Inc. | Griscom Paul SVP and Controller | Sell · S | 10,077 | $25.63 | $258.3K | Mild sell-18 | ||
3d ago Jun 25, 2026 | Definium Therapeutics, Inc. | Karlin Daniel Chief Medical Officer | Sell · S | 10,035 | $45.03 | $451.9K | Neutral+1 | 10b5-1 | |
3d ago Jun 25, 2026 | Definium Therapeutics, Inc. | Barrow Robert Chief Executive Officer · Director | Sell · S | 29,208 | $45.03 | $1.32M | Neutral+4 | 10b5-1 | |
3d ago Jun 24, 2026 | Context Therapeutics Inc. | West Linda Director | Buy · A | 45,000 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 25, 2026 | CHURCH & DWIGHT CO INC /DE/ | Raup Charles R President US Domestic | Sell · F | 853 | $98.15 | $83.7K | Neutral+5 | ||
3d ago Jun 25, 2026 | Jade Biosciences, Inc. | Eisner Mark Director | Buy · A | 47,675 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 24, 2026 | VTEX | do Carmo Thomaz Junior Geraldo Chief Executive Officer | Sell · C | 1,000,000 | $0.00 | $0 | Neutral+5 | Deriv | |
3d ago Jun 24, 2026 | VTEX | do Carmo Thomaz Junior Geraldo Chief Executive Officer | Buy · C | 1,000,000 | $0.00 | $0 | Neutral+5 | ||
3d ago Jun 24, 2026 | VTEX | Gomide de Faria Mariano Chief Executive Officer | Sell · C | 1,000,000 | $0.00 | $0 | Neutral+5 | Deriv | |
3d ago Jun 24, 2026 | VTEX | Gomide de Faria Mariano Chief Executive Officer | Buy · C | 1,000,000 | $0.00 | $0 | Neutral+5 | ||
3d ago Jun 25, 2026 | Rush Street Interactive, Inc. | WIERBICKI PAUL Chief Legal Officer · Director | Buy · M | 6,926 | $0.00 | $0 | Neutral-6 | Deriv | |
3d ago Jun 25, 2026 | Rush Street Interactive, Inc. | WIERBICKI PAUL Chief Legal Officer · Director | Buy · M | 3,074 | $0.00 | $0 | Neutral-6 | Deriv | |
3d ago Jun 25, 2026 | Rush Street Interactive, Inc. | WIERBICKI PAUL Chief Legal Officer · Director | Sell · S | 10,000 | $30.12 | $301.2K | Neutral-6 | ||
3d ago Jun 25, 2026 | Rush Street Interactive, Inc. | WIERBICKI PAUL Chief Legal Officer · Director | Buy · M | 6,926 | $10.70 | $74.1K | Neutral-6 | ||
3d ago Jun 25, 2026 | Rush Street Interactive, Inc. | WIERBICKI PAUL Chief Legal Officer · Director | Buy · M | 3,074 | $5.79 | $17.8K | Neutral-6 | ||
3d ago Jun 24, 2026 | DoorDash, Inc. | Fang Andy Director | Sell · J | 5,000 | $0.00 | $0 | Neutral-10 | Deriv | |
3d ago Jun 24, 2026 | DoorDash, Inc. | Fang Andy Director | Sell · S | 5,000 | $180.00 | $900.0K | Neutral-10 | 10b5-1 | |
3d ago Jun 24, 2026 | DoorDash, Inc. | Fang Andy Director | Buy · J | 5,000 | $0.00 | $0 | Neutral-10 | ||
3d ago Jun 24, 2026 | Context Therapeutics Inc. | Pasternak Andy Director | Buy · A | 45,000 | $0.00 | $0 | Neutral+2 | Deriv | |
3d ago Jun 25, 2026 | CITIZENS FINANCIAL SERVICES INC | Guillaume Stephen J EXECUTIVE VICE PRESIDENT | Buy · A | 311 | $0.00 | $0 | Neutral+5 | ||
3d ago Jun 25, 2026 | IONIS PHARMACEUTICALS INC | Swayze Eric EVP Research | Sell · S | 10,602 | $79.18 | $839.5K | Mild sell-21 | ||
3d ago Jun 26, 2026 | BETA Technologies, Inc. | Clark Kyle SEE REMARKS · Director | Sell · S | 15,000 | $16.51 | $247.6K | Neutral-1 | 10b5-1 | |
3d ago Jun 25, 2026 | BETA Technologies, Inc. | Clark Kyle SEE REMARKS · Director | Sell · S | 15,000 | $15.79 | $236.8K | Neutral-1 | 10b5-1 | |
3d ago Jun 24, 2026 | BETA Technologies, Inc. | Clark Kyle SEE REMARKS · Director | Sell · S | 15,000 | $15.83 | $237.4K | Neutral-1 | 10b5-1 | |
3d ago Jun 25, 2026 | MGIC INVESTMENT CORP | Colson Nathaniel H Officer EVP, CFO & CRO | Sell · S | 20,000 | $27.10 | $542.0K | Neutral+1 | 10b5-1 | |
3d ago Jun 26, 2026 | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C Chief Financial Officer | Buy · P | 100 | $26.39 | $2.6K | Bullish+50 | ||
3d ago Jun 26, 2026 | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C Chief Financial Officer | Buy · P | 1,358 | $25.55 | $34.7K | Bullish+50 | ||
3d ago Jun 26, 2026 | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C Chief Financial Officer | Buy · P | 4,212 | $24.90 | $104.9K | Bullish+50 | ||
3d ago Jun 26, 2026 | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C Chief Financial Officer | Buy · P | 580 | $23.61 | $13.7K | Bullish+50 | ||
3d ago Jun 24, 2026 | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C Chief Financial Officer | Buy · P | 100 | $27.77 | $2.8K | Bullish+50 | ||
3d ago Jun 24, 2026 | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C Chief Financial Officer | Buy · P | 3,400 | $26.98 | $91.7K | Bullish+50 | ||
3d ago Jun 24, 2026 | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C Chief Financial Officer | Buy · P | 3,000 | $25.98 | $77.9K | Bullish+50 | ||
3d ago Jun 24, 2026 | Faeth Therapeutics, Inc. | STEPHENSON BRIAN C Chief Financial Officer | Buy · P | 2,891 | $25.22 | $72.9K | Bullish+50 |